X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs AJANTA PHARMA - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN LTD AJANTA PHARMA LUPIN LTD/
AJANTA PHARMA
 
P/E (TTM) x 16.7 20.5 81.6% View Chart
P/BV x 3.9 8.9 44.0% View Chart
Dividend Yield % 0.8 0.7 116.7%  

Financials

 LUPIN LTD   AJANTA PHARMA
EQUITY SHARE DATA
    LUPIN LTD
Mar-16
AJANTA PHARMA
Mar-16
LUPIN LTD/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs2,1271,720 123.7%   
Low Rs1,2941,103 117.3%   
Sales per share (Unadj.) Rs304.1194.6 156.3%  
Earnings per share (Unadj.) Rs50.445.2 111.4%  
Cash flow per share (Unadj.) Rs60.750.3 120.7%  
Dividends per share (Unadj.) Rs7.508.00 93.8%  
Dividend yield (eoy) %0.40.6 77.4%  
Book value per share (Unadj.) Rs243.8132.0 184.6%  
Shares outstanding (eoy) m450.5888.77 507.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.67.3 77.6%   
Avg P/E ratio x33.931.2 108.7%  
P/CF ratio (eoy) x28.228.1 100.4%  
Price / Book Value ratio x7.010.7 65.6%  
Dividend payout %14.917.7 84.1%   
Avg Mkt Cap Rs m770,740125,299 615.1%   
No. of employees `00016.4NA-   
Total wages/salary Rs m21,0772,570 820.1%   
Avg. sales/employee Rs Th8,379.6NM-  
Avg. wages/employee Rs Th1,289.0NM-  
Avg. net profit/employee Rs Th1,388.7NM-  
INCOME DATA
Net Sales Rs m137,01617,275 793.1%  
Other income Rs m1,877166 1,128.7%   
Total revenues Rs m138,89317,442 796.3%   
Gross profit Rs m37,5355,807 646.3%  
Depreciation Rs m4,635451 1,028.6%   
Interest Rs m44649 912.5%   
Profit before tax Rs m34,3305,474 627.2%   
Minority Interest Rs m-880-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m11,5361,460 790.2%   
Profit after tax Rs m22,7074,014 565.7%  
Gross profit margin %27.433.6 81.5%  
Effective tax rate %33.626.7 126.0%   
Net profit margin %16.623.2 71.3%  
BALANCE SHEET DATA
Current assets Rs m97,7907,639 1,280.2%   
Current liabilities Rs m53,8722,715 1,984.5%   
Net working cap to sales %32.128.5 112.5%  
Current ratio x1.82.8 64.5%  
Inventory Days Days8543 195.9%  
Debtors Days Days12179 154.1%  
Net fixed assets Rs m86,3796,914 1,249.4%   
Share capital Rs m901177 509.4%   
"Free" reserves Rs m105,73511,442 924.1%   
Net worth Rs m109,84411,721 937.2%   
Long term debt Rs m53,739149 36,139.2%   
Total assets Rs m224,37814,814 1,514.6%  
Interest coverage x77.9112.9 69.0%   
Debt to equity ratio x0.50 3,856.1%  
Sales to assets ratio x0.61.2 52.4%   
Return on assets %10.327.4 37.6%  
Return on equity %20.734.2 60.4%  
Return on capital %21.246.5 45.6%  
Exports to sales %49.155.1 89.0%   
Imports to sales %7.46.0 123.9%   
Exports (fob) Rs m67,2449,527 705.8%   
Imports (cif) Rs m10,1991,038 983.0%   
Fx inflow Rs m71,40510,422 685.1%   
Fx outflow Rs m17,8071,678 1,061.1%   
Net fx Rs m53,5988,744 613.0%   
CASH FLOW
From Operations Rs m-3,6903,264 -113.0%  
From Investments Rs m-69,434-2,093 3,317.6%  
From Financial Activity Rs m58,126-1,186 -4,902.3%  
Net Cashflow Rs m-14,998-15 101,337.8%  

Share Holding

Indian Promoters % 46.6 73.8 63.1%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 1.6 729.0%  
FIIs % 31.9 7.6 419.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 17.0 59.4%  
Shareholders   98,259 20,968 468.6%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN LTD With:   DIVIS LABORATORIES  GLENMARK PHARMA  AUROBINDO PHARMA  PLETHICO PHARMA  FDC LTD.  

Compare LUPIN LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Higher; Realty & Pharma Stocks Lead(09:30 am)

Asian stock indices are trading mixed today. The Shanghai Composite is lower by 0.29% while the Hang Seng is even. The Nikkei 225 is trading higher by 0.46%.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Aug 23, 2017 10:45 AM

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE LUPIN LTD WITH

MARKET STATS